OrphageniX Inc., a new biotechnology company founded by University of Delaware researchers, has been established in Wilmington, Del., to develop and commercialize UD-patented technologies for repairing genes that cause rare, hereditary diseases such as sickle cell anemia and spinal muscular atrophy.
Researchers from the Schulich School of Medicine & Dentistry at The University of Western Ontario , working with a group from Edinburgh, have discovered a way to kill the cystic fibrosis superbug, Burkholderia cenocepacia.
Performance league tables are linked to lower death rates after major heart surgery, reveals research published ahead of print in the journal Heart.
Research led by Dartmouth scientists found that animals fed nutritious, high-quality food end up with much lower concentrations of toxic methylmercury in their tissues.
Analysis of three genetic mechanisms that cause nonsmall cell lung cancer might explain why East Asians respond better than other ethnic groups to a certain type of chemotherapy, a team led by UT Southwestern Medical Center researchers has found.
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.
When it comes to cholesterol-lowering drugs, more is better. At least, that?s what heart doctors and heart patients have been hearing in recent years. And as a result, more patients are taking higher doses of drugs called statins ? leading to lower heart and stroke risk, but higher prescription drug costs and more frequent side effects.
A team from the Friedman School of Nutrition Science and Policy at Tufts University is providing technical assistance to the East and Southern Africa Regional Office of the United Nations Children?s Fund (EASRO UNICEF), the Food and Agriculture Organization of the United Nations (FAO), and the government of Kenya to build strategies for implementing Kenya?s National Food and Nutrition Policy.
Australian scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia.
German researchers have found a natural component of human blood that block the HIV virus from infecting cells, and would be more potent to fight the HIV virus.